摘要
肿瘤微环境是上皮癌细胞和非转化基质细胞的复杂网络。在许多基质细胞类型中,成纤维细胞是最多的,并且传统上被认为是癌症进展的支持元件。许多研究表明,癌细胞与相关的成纤维细胞发生积极的串扰,以获得关键资源,如生长因子和营养素。癌症中成纤维细胞“谋杀谋杀”的方面是多重的。然而,最近针对消耗肿瘤成纤维细胞的治疗尝试,扰乱了相当简单的图片。与预期相反,缺乏成纤维细胞的肿瘤加速了其进展,而患者的结果较差。这些研究提醒我们,即使在癌症的存在下,成纤维细胞在保持组织稳态方面的生理学作用。越来越清楚,我们对先进肿瘤的研究偏重于我们对肿瘤生物学中成纤维细胞作用的理解。成纤维细胞保护组织免受恶性转化的许多事件在很大程度上未被确认,因为肿瘤是不可见的。目前的审查有望提供一个比较平衡的成像细胞功能在癌症进展和治疗抵抗力的观点。我们将讨论是否有可能与成纤维细胞协同作为抗肿瘤进展和治疗抗性的治疗概念。
关键词: CAF,异质性,转移,微环境,胰腺癌,TGF-β1
Current Medicinal Chemistry
Title:Collaborative and Defensive Fibroblasts in Tumor Progression and Therapy Resistance
Volume: 24 Issue: 26
关键词: CAF,异质性,转移,微环境,胰腺癌,TGF-β1
摘要: Tumor microenvironment is a complex network of epithelial cancer cells and non-transformed stromal cells. Of the many stromal cell types, fibroblasts are the most numerous ones and are traditionally viewed as supportive elements of cancer progression. Many studies show that cancer cells engage in active crosstalk with associated fibroblasts in order to obtain key resources, such as growth factors and nutrients. The facets of fibroblast “complicity to murder” in cancer are multiple. However, recent therapeutic attempts aiming at depleting fibroblasts from tumors, perturbed rather simplistic picture. Contrary to the expectations, tumors devoid of fibroblasts accelerated their progression while patients faced poorer outcomes. These studies remind us of the physiologic roles fibroblasts have in maintaining tissue homeostasis even in the presence of cancer. It is becoming increasingly clear that our research focus on advanced tumors has biased our understanding of fibroblast role in tumor biology. The numerous events where the fibroblasts protect the tissue from malignant transformation remain largely unacknowledged, as the tumors are invisible. The present review has the ambition to offer a more balanced view of fibroblasts functions in cancer progression and therapy resistance. We will address the question whether it is possible to synergize the efforts with fibroblasts as the therapeutic concept against tumor progression and therapy resistance.
Export Options
About this article
Cite this article as:
Collaborative and Defensive Fibroblasts in Tumor Progression and Therapy Resistance, Current Medicinal Chemistry 2017; 24 (26) . https://dx.doi.org/10.2174/0929867324666170428104311
DOI https://dx.doi.org/10.2174/0929867324666170428104311 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of Bacterial Lipopolysaccharides as Immune Modulator in Vaccine and Drug Development
Endocrine, Metabolic & Immune Disorders - Drug Targets Transplantation of Pancreatic Islets Immobilized in Alginate-Based Microcapsules: From Animal Studies to Clinical Trials
Micro and Nanosystems Circulating MicroRNAs and Blood-Brain-Barrier Function in Breast Cancer Metastasis
Current Pharmaceutical Design STAT 3 as a Target for Cancer Drug Discovery
Current Medicinal Chemistry Stem Cells for Microenvironmental Modulation and Retinal Regeneration
Current Tissue Engineering (Discontinued) SENP1 as A Biomarker for the Diagnosis of Cancer: Review of the Science and Published Patents
Recent Patents on Biomarkers Proteomic Analysis of Mitochondrial Proteins on the Mechanism of Apoptotic Under Amorphophallus konjac Tuber (KONJAC) Extracts in Gas tric Cancer Cell
Current Proteomics Experimental Strategies in Autoimmunity: Antagonists of Cytokines and their Receptors, Nanocarriers, Inhibitors of Immunoproteasome, Leukocyte Migration and Protein Kinases
Current Pharmaceutical Design Antiangiogenesis in Myelodysplastic Syndrome
Current Cancer Drug Targets The Mechanisms Responsible for Garlic - Drug Interactions and their In Vivo Relevance
Current Drug Metabolism Meet Our Editorial Board Member:
Recent Patents on Anti-Cancer Drug Discovery Targeting Cell Death and Survival Receptors in Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Post-Exercise Ketosis, Salivary Uric Acid and Interleukin-6 after a Simulated Wheelchair Basketball Match
Endocrine, Metabolic & Immune Disorders - Drug Targets Peroxisome Proliferator-Activated Receptors: Role of Isoform Gamma in the Antineoplastic Effect of Iodine in Mammary Cancer
Current Cancer Drug Targets Targeting CD4 to Disrupt Signaling Through Membrane Rafts: Towards a Raft-Based Therapeutics
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Strategies to Overcome Multi-Drug Resistance in Cancer Cells: the Contribution of siRNA and Nanotechnologies
Current Organic Chemistry Traditional Fruits of Kerala: Bioactive Compounds and their Curative Potential in Chronic Diseases
Current Nutrition & Food Science Editorial (Thematic issue: Discovering New Anticancer Activities from Old Drugs)
Current Medicinal Chemistry Microbiology of the Human Intestinal Tract and Approaches for Its Dietary Modulation
Current Pharmaceutical Design Peptide Aptamers with Biological and Therapeutic Applications
Current Medicinal Chemistry